A systematic review of the definitions, determinants, and clinical outcomes of antimicrobial de-escalation in the intensive care unit.
Open accessThe DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
Antimicrobial de-escalation (ADE) is a strategy to reduce the spectrum of antimicrobials and aims to prevent the emergence of bacterial resistance. We present a systematic review describing the definitions, determinants and outcomes associated with ADE. We included 2 randomized controlled trials and 12 cohort studies. There was considerable variability in the definition of ADE. It was more frequently performed in patients with broad-spectrum and/or appropriate antimicrobial therapy (P= .05 to .002), when more agents were used (P= .002), and in the absence of multidrug-resistant pathogens (P< .05). Where investigated, lower or improving severity scores were consistently associated with ADE (P= .04 to <.001). The pooled effect of ADE on mortality is protective (relative risk, 0.68; 95% confidence interval, .52-.88). Because the determinants of ADE are markers of clinical improvement and/or of lower risk of treatment failure this effect on mortality cannot be retained as evidence. None of the studies were designed to investigate the effect of ADE on antimicrobial resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most studies were observational, and there are concerns that de-escalation is used primarily in patients who are getting better, which is why the reported improved short-term mortality should be interpreted with caution [277, 279].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [279]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Measurement of Observer Agreement for Categorical Data
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529310 · Cited by 81,148 · cited 1×
“Interrater agreement was calculated with free marginal κ statistics [8].”
MethodMeasuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · cited 1×
“Heterogeneity among studies was evaluated using the χ(2) test based on the Cochran Q statistic and quantified by the I(2) value [9].”
MethodMeta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 4×
“by DerSimonian and Laird [10], with the Egger test used for publication bias.”
MethodInfluentialCochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
(2014) · Medical Entomology and Zoology · Cited by 17,633
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877
Dellit, T. H., Owens, R. C., McGowan, J. E., Gerding, D. N., Weinstein, R. A., Burke, J. P., Huskins, W. C., Paterson, D. L., Fishman, N. O., Carpenter, C. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510393 · Cited by 3,362
SINGH, N., ROGERS, P., ATWOOD, C. W., WAGENER, M. M., & YU, V. L. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.2.9909095 · Cited by 1,032 · cited 1×
“has been studied for shortening treatment [27], to date there is no evidence of this for ADE because none of the published studies was designed to evaluate this variable.”
BackgroundGarnacho-Montero, J., Gutiérrez-Pizarraya, A., Escoresca-Ortega, A., Corcia-Palomo, Y., Fernández-Delgado, E., Herrera-Melero, I., Ortiz-Leyba, C., & Márquez-Vácaro, J. A. (2014) · Intensive Care Medicine · doi:10.1007/s00134-013-3077-7 · Cited by 389 · cited 12×
“GarnachoMontero et al [22] 2014 No specific antimicrobials described Yes Yes No Yes Not ranked Once culture results were available”
BackgroundMethodResultInfluentialSelf-citationEmergence of Imipenem-Resistant Gram-Negative Bacilli in Intestinal Flora of Intensive Care Patients
Armand-Lefèvre, L., Angebault, C., Barbier, F., Hamelet, E., Defrance, G., Ruppé, E., Bronchard, R., Lepeule, R., Lucet, J.-C., El Mniai, A., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01823-12 · Cited by 300 · cited 1×
“bials have been associated with resistance among gastrointestinal tract flora [28].”
BackgroundLeone, M., Bechis, C., Baumstarck, K., Lefrant, J.-Y., Albanèse, J., Jaber, S., Lepape, A., Constantin, J.-M., Papazian, L., Bruder, N., et al. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3411-8 · Cited by 243 · cited 14×
“The other study randomized ADE and a continuation strategy in 120 patients treated with antibiotics for severe sepsis in 9 ICUs [23].”
BackgroundMethodInfluentialElaboration of a consensual definition of de-escalation allowing a ranking of β-lactams
Weiss, E., Zahar, J.-R., Lesprit, P., Ruppe, E., Leone, M., Chastre, J., Lucet, J.-C., Paugam-Burtz, C., Brun-Buisson, C., Timsit, J.-F., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.03.013 · Cited by 180 · cited 3×
“Weiss and a group of French-speaking experts [25] used a Delphi method to propose a definition of ADE.”
MethodResultInfluentialSelf-citationMokart, D., Slehofer, G., Lambert, J., Sannini, A., Chow‐Chine, L., Brun, J. P., Berger, P., Duran, S., Faucher, M., Blache, J. L., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-013-3148-9 · Cited by 137 · cited 9×
“Likewise, an initial empiric broad-spectrum treatment [19, 21], compliance with guidelines to start antipseudomonal β-lactams in neutropenic patients (P = .”
BackgroundInfluentialÁlvarez-Lerma, F., Alvarez, B., Luque, P., Ruiz, F., Dominguez-Roldan, J.-M., Quintana, E., Sanz-Rodriguez, C., & the ADANN Study Group (2006) · Critical Care · doi:10.1186/cc4919 · Cited by 127 · cited 9×
“One study was multicentric [11], 4 were prospective”
BackgroundInfluentialMorel, J., Casoetto, J., Jospé, R., Aubert, G., Terrana, R., Dumont, A., Molliex, S., & Auboyer, C. (2010) · Critical Care · doi:10.1186/cc9373 · Cited by 126 · cited 7×
“more, confounders such as an incompletely described cohort [12], an imbalance in patient characteristics at baseline [15, 23], or “at the moment of ADE” [16, 20] introduced high risk of bias.”
BackgroundInfluentialDe-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock
Silva, B. N., Andriolo, R. B., Atallah, Á. N., & Salomão, R. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007934.pub3 · Cited by 107
Eachempati, S. R., Hydo, L. J., Shou, J., & Barie, P. S. (2009) · Journal of Trauma: Injury, Infection & Critical Care · doi:10.1097/ta.0b013e31819dca4e · Cited by 105 · cited 3×
“Eachempati et al [13] 2009 Surgical patients with VAP 1 138 Retrospective observational ICU admission Recurrence of pneumonia; all-cause mortality 57 4/8”
BackgroundAntibiotic strategies in severe nosocomial sepsis: Why do we not de-escalate more often?*
Heenen, S., Jacobs, F., & Vincent, J.-L. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182416ecf · Cited by 100 · cited 6×
“Heenen et al [17] 2012 Hospital-acquired severe sepsis 1 169 Retrospective observational ICU admission All-cause mortality 81 5/8”
BackgroundInfluentialGiantsou, E., Liratzopoulos, N., Efraimidou, E., Panopoulou, M., Alepopoulou, E., Kartali-Ktenidou, S., & Manolas, K. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0619-x · Cited by 100 · cited 7×
“more, confounders such as an incompletely described cohort [12], an imbalance in patient characteristics at baseline [15, 23], or “at the moment of ADE” [16, 20] introduced high risk of bias.”
BackgroundResultInfluentialImpact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia
Joung, K. M., Lee, J.-A., Moon, S.-Y., Cheong, H. S., Joo, E.-J., Ha, Y.-E., Sohn, K. M., Chung, S. M., Suh, G. Y., Chung, D. R., et al. (2011) · Critical Care · doi:10.1186/cc10072 · Cited by 100 · cited 12×
“more, confounders such as an incompletely described cohort [12], an imbalance in patient characteristics at baseline [15, 23], or “at the moment of ADE” [16, 20] introduced high risk of bias.”
BackgroundInfluentialMadaras-Kelly, K., Jones, M., Remington, R., Hill, N., Huttner, B., & Samore, M. (2014) · Infection Control & Hospital Epidemiology · doi:10.1086/677633 · Cited by 99 · cited 1×
“Madaras-Kelly and colleagues [26] developed a spectrum score and calculated piperacillin-tazobactam at a higher value”
BackgroundGonzalez, L., Cravoisy, A., Barraud, D., Conrad, M., Nace, L., Lemarié, J., Bollaert, P.-E., & Gibot, S. (2013) · Critical Care · doi:10.1186/cc12819 · Cited by 89 · cited 8×
“Gonzalez et al [19] 2013 No specific antimicrobials described Yes Yes Yes Yes Not ranked Specified when no obvious infectious site: discontinuation before 4th d if favorable clinical evolution/ alternative diagnosis”
BackgroundInfluentialDe-escalation after empirical meropenem treatment in the intensive care unit: Fiction or reality?
Waele, J. J. D., Ravyts, M., Depuydt, P. O., Blot, S. I., Decruyenaere, J. M. A., & Vogelaers, D. (2010) · Journal of Critical Care · doi:10.1016/j.jcrc.2009.11.007 · Cited by 75 · cited 5×
“De Waele et al [14] 2010 Surgical patients treated with meropenem 1 113 Retrospective observational ICU admission All-cause mortality 42 5/8”
BackgroundInfluentialKim, J. W., Chung, J., Choi, S.-H., Jang, H. J., Hong, S.-B., Lim, C.-M., & Koh, Y. (2012) · Critical Care · doi:10.1186/cc11197 · Cited by 72 · cited 3×
“Kim et al [18] 2012 ADE group: imipenem + vancomycin; non-ADE group: empiric antimicrobials according to national guidelines for nosocomial pneumonia Yes Yes No Yes Not ranked 3 to 5th d”
BackgroundMethodAntimicrobial de-escalation in septic cancer patients: is it safe to back down?
Paskovaty, A., Pastores, S. M., Gedrimaite, Z., Kostelecky, N., Riedel, E. R., & Seo, S. K. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-4016-6 · Cited by 40 · cited 12×
“A lower baseline severity [11, 24] or clinical resolution at the”
BackgroundInfluentialDoes Antibiotic De-escalation for Nosocomial Pneumonia Impact Intensive Care Unit Length of Stay?
Knaak, E., Cavalieri, S. J., Elsasser, G. N., Preheim, L. C., Gonitzke, A., & Destache, C. J. (2012) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e318279ee87 · Cited by 28 · cited 10×
“more, confounders such as an incompletely described cohort [12], an imbalance in patient characteristics at baseline [15, 23], or “at the moment of ADE” [16, 20] introduced high risk of bias.”
BackgroundInfluentialCarlier, M., Roberts, J. A., Stove, V. V., Verstraete, A., Lipman, J., & Waele, J. J. D. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00409-15 · Cited by 21 · cited 1×
“superinfections with ADE in a randomized trial [23], of which 44%were due to the initial pathogen, might be related to the higher risk of nonachievement of pharmacokinetic/pharmacodynamic targets with narrow-spectrum compared with broad-spectrum antimicrobials found in simulation studies [29].”
BackgroundSelf-citation
Research works printed but not linked: 1
- Effective Practice and Organisation of Care (EPOC). EPOC resources for review authors. Oslo, Norway: Norwegian Knowledge Centre for the Health Services; 2014. Available at: http://epoc.cochrane.org/epoc-specific-resources-review-authors. Accessed 19 January 2016.
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Self-citationSurviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Self-citationTorres, A., Niederman, M. S., Chastre, J., Ewig, S., Fernandez-Vandellos, P., Hanberger, H., Kollef, M., Li Bassi, G., Luna, C. M., Martin-Loeches, I., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00582-2017 · Cited by 1,387
Self-citationBloodstream infections in critically ill patients: an expert statement
Timsit, J.-F., Ruppé, E., Barbier, F., Tabah, A., & Bassetti, M. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05950-6 · Cited by 448
Self-citationSartelli, M., Guirao, X., Hardcastle, T. C., Kluger, Y., Boermeester, M. A., Raşa, K., Ansaloni, L., Coccolini, F., Montravers, P., Abu-Zidan, F. M., et al. (2018) · World Journal of Emergency Surgery · doi:10.1186/s13017-018-0219-9 · Cited by 301
“cornerstones of antimicrobial stewardship programs [116].”
Metadata
- Authors
- Tabah, A., Cotta, M. O., Garnacho-Montero, J., Schouten, J., Roberts, J. A., Lipman, J., Tacey, M., Timsit, J.-F., Leone, M., Zahar, J. R., & De Waele, J. J.
- Affiliations
- Royal Brisbane and Women's Hospital (AU)
- The University of Queensland (AU)
- Canisius-Wilhelmina Ziekenhuis (NL)
- Queensland University of Technology (AU)
- The Royal Melbourne Hospital (AU)
- Centre Hospitalier Universitaire d'Angers (FR)
- Corresponding author
- Tabah, Alexis
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-12-23
- Volume
- 62
- Issue
- 8
- Pages
- 1009-1017
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2253853790
- Cited by
- 220
- References
- 29
- Citations by year
- 2026: 14 · 2025: 13 · 2024: 20 · 2023: 18 · 2022: 31 · 2021: 13 · 2020: 26 · 2019: 24 · 2018: 25 · 2017: 21 · 2016: 14 · 2015: 1
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- Locations
- Clinical Infectious Diseases (publishedVersion, other-oa)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, other-oa)
- Funders
- Pfizer
- AstraZeneca
- Gilead Sciences
- Fonds Wetenschappelijk Onderzoek
- Astellas Pharma
- Vlaamse regering
- European Society of Intensive Care Medicine
- Medical Research Council
- National Health and Medical Research Council (1099452, 1048652)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- antibiotic de-escalation, intensive care unit, antimicrobial resistance, mortality, broad-spectrum antimicrobial therapy, multidrug-resistant pathogens, severity scoring, clinical outcomes
- MeSH terms
- Anti-Bacterial Agents, Bacterial Infections, Clinical Trials as Topic, Cross Infection, Drug Resistance, Microbial, Humans, Intensive Care Units, Severity of Illness Index, Cohort Studies, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.